Conference on ‘ Future food and health ’ Symposium II : Diet – gene interactions ; implications for future diets and health Personalised nutrition : ready for practice ?

The efficacy by which dietary interventions influence risk markers of multi-factorial diseases is mainly determined by taking population-based approaches. However, there exists considerable inter-individual variation in response to dietary interventions, and some interventions may benefit certain individuals or population subgroups more than others. This review evaluates the application of nutrigenomic technologies to further the concept of personalised nutrition, as well as the process to take personalised nutrition to the marketplace. The modulation of an individual's response is influenced by both genetic and environmental factors. Many nutrigenetics studies have attempted to explain variability in responses based on a single or a few genotypes so that a genotype may be used to define personalised dietary advice. It has, however, proven very challenging to define an individual's responsiveness to complex diets based on common genetic variations. In addition, there is a limited understanding of what constitutes an optimal response because we lack key health biomarkers and signatures. In conclusion, advances in nutrigenomics will undoubtedly further the understanding of the complex interplay between genotype, phenotype and environment, which are required to enhance the development of personalised nutrition in the future. At the same time, however, issues relating to consumer acceptance, privacy protection as well as marketing and distribution of personalised products need to be addressed before personalised nutrition can become commercially viable.

[1]  A Tremblay,et al.  The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.

[2]  L. J. Frewer,et al.  Consumer acceptance of technology-based food innovations: Lessons for the future of nutrigenomics , 2007, Appetite.

[3]  C. Drevon,et al.  Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. , 2010, The American journal of clinical nutrition.

[4]  H. Cordell,et al.  The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. , 2011, Annual review of nutrition.

[5]  Christine M. Williams,et al.  Personalised nutrition: status and perspectives , 2007, British Journal of Nutrition.

[6]  A. Minihane,et al.  Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? , 2009, Proceedings of the Nutrition Society.

[7]  P. Calder,et al.  Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. , 2008, The American journal of clinical nutrition.

[8]  B. Ommen Personalized nutrition from a health perspective: luxury or necessity? , 2007, Genes & Nutrition.

[9]  M. Koelen,et al.  Communication on personalised nutrition: individual-environment interaction , 2007, Genes & Nutrition.

[10]  A. Minihane,et al.  Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. , 2010, Atherosclerosis.

[11]  R. Renes,et al.  Consumer acceptance of nutrigenomics-based personalised nutrition , 2008, British Journal of Nutrition.

[12]  A. Minihane Fatty acid-genotype interactions and cardiovascular risk. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  A. Campbell,et al.  Systemic lactose intolerance: a new perspective on an old problem , 2005, Postgraduate Medical Journal.

[14]  A. Nizel Personalized nutrition counseling. , 1972, ASDC journal of dentistry for children.

[15]  L. Cupples,et al.  Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. , 2009, The American journal of clinical nutrition.

[16]  G. Rose Sick individuals and sick populations. , 2001, International journal of epidemiology.

[17]  L. Cupples,et al.  Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. , 2010, The Journal of clinical endocrinology and metabolism.

[18]  P. Whincup,et al.  Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[19]  Paul T. Williams,et al.  Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1. , 2004, The American journal of clinical nutrition.

[20]  C. Shuman,et al.  Direct‐to‐consumer genetic testing: good, bad or benign? , 2010, Clinical genetics.

[21]  Jean-Daniel Zucker,et al.  Horizons in nutritional science : The case for strategic international alliances to harness nutritional genomics for public and personal health. , 2005 .

[22]  B. Bunting,et al.  Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers , 2008, British Journal of Nutrition.

[23]  P. Talmud,et al.  ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  L. Brennan,et al.  Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. , 2011, Molecular nutrition & food research.

[25]  J. Mathers,et al.  Effects on nutrient intake of a family-based intervention to promote increased consumption of low-fat starchy foods through education, cooking skills and personalised goal setting: the Family Food and Health Project. , 2012, The British journal of nutrition.